Our partners at PYA have released a new white paper explaining how competing health systems may overcome antitrust obstacles to merger by formally committing to population health improvement in the communities they serve.

PYA, a national healthcare consulting and professional services firm, has released a white paper, “Overcoming Antitrust Obstacles to Mergers by Committing to Population Health Improvement.”  The white paper discusses the challenges antitrust laws can create for healthcare providers contemplating consolidation; explores the pro-competitive benefits of consolidation when the new entity commits to population health; and explains how providers may pursue Certificates of Public Advantage and similar state programs to eliminate federal antitrust concerns.

In one such case, the white paper notes, “[t]hrough a three-year process, [the merged providers] were able to demonstrate that consolidation, not continued competition, is in the best interests of the communities they serve.  The investments [the newly consolidated entity] has committed to make would not be possible if the inefficiencies of operating two separate organizations had continued.”

This white paper is derived from a PYA article originally published in the AHLA Transactions Guide.  The Guide features up-to-date information and legal news and analysis for healthcare attorneys.

With extensive experience in mergers and acquisitions and other healthcare transactions, PYA’s cross-functional teams partner with clients and legal counsel in all 50 states to craft solutions that create the greatest value from business combinations.  Founded in 1983, PYA leverages a deep industry knowledge base and dedicated, healthcare-savvy professionals to provide expertise throughout the full cycle of the transaction.

The post PYA White Paper Explains How Pro-Competitive Impacts of Hospital Consolidation Can Overcome Antitrust Concerns appeared first on PYA.

Share This